| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVALANCHE BIOTECHNOLOGIES IN | 15,000 | 244,000 | 0.08% | ||
| 2 | Neothetics Inc | 43,000 | 387,000 | 0.13% | ||
| 3 | XENON PHARMACEUTICALS INC | 37,500 | 432,000 | 0.14% | ||
| 4 | GLAUKOS CORP | 15,000 | 435,000 | 0.14% | ||
| 5 | OCERA THERAPEUTICS INC | 125,000 | 475,000 | 0.15% | ||
| 6 | XOMA CORP DEL | 125,000 | 485,000 | 0.16% | ||
| 7 | BIOLASE INC | 300,000 | 522,000 | 0.17% | ||
| 8 | KINDRED BIOSCIENCES INC | 93,500 | 638,000 | 0.21% | ||
| 9 | BIOCRYST PHARMACEUTICALS | 45,000 | 672,000 | 0.22% | ||
| 10 | Nivalis Therapeutics Inc | 50,000 | 758,000 | 0.25% | ||
| 11 | BioDelivery Sciences International Inc | 106,200 | 845,000 | 0.27% | Call | |
| 12 | VERACYTE INC | 78,386 | 873,000 | 0.28% | ||
| 13 | UNILIFE CORP | 450,000 | 968,000 | 0.31% | ||
| 14 | Ascendis Pharma | 63,739 | 1,127,000 | 0.37% | ||
| 15 | ADAPTIMMUNE THERAPEUTICS PLC | 76,850 | 1,409,000 | 0.46% | ||
| 16 | VERSARTIS INC COM | 100,000 | 1,522,000 | 0.49% | ||
| 17 | RADIUS HEALTH | 25,000 | 1,693,000 | 0.55% | ||
| 18 | TONIX PHARMACEUTICALS HLD | 202,500 | 1,816,000 | 0.59% | ||
| 19 | PUMA BIOTECHNOLOGY | 17,500 | 2,043,000 | 0.66% | ||
| 20 | SAGE THERAPEUTICS | 31,700 | 2,314,000 | 0.75% | Call | |
| 21 | BioDelivery Sciences International Inc | 300,000 | 2,388,000 | 0.77% | ||
| 22 | AVALANCHE BIOTECHNOLOGIES IN | 150,000 | 2,436,000 | 0.79% | Call | |
| 23 | Foamix Pharmaceuticals Ltd. | 250,000 | 2,563,000 | 0.83% | ||
| 24 | AXOVANT SCIENCES LTD | 135,000 | 2,751,000 | 0.89% | ||
| 25 | THERAPEUTICSMD INC | 400,000 | 3,144,000 | 1.02% | ||
| 26 | Lion Biotechnologies | 350,000 | 3,210,000 | 1.04% | ||
| 27 | KEMPHARM INC | 175,000 | 3,215,000 | 1.04% | ||
| 28 | ROCKWELL MED INC COM | 200,000 | 3,224,000 | 1.04% | Call | |
| 29 | ANTHEM INC | 20,000 | 3,283,000 | 1.06% | ||
| 30 | ASSEMBLY BIOSCIENCES INC | 175,000 | 3,371,000 | 1.09% | ||
| 31 | GENOCEA BIOSCIENCES INC | 270,000 | 3,707,000 | 1.20% | ||
| 32 | Sunesis Pharmaceuticals I | 1,250,000 | 3,763,000 | 1.22% | ||
| 33 | ALCOBRA LTD | 600,000 | 3,924,000 | 1.27% | ||
| 34 | WRIGHT MEDICAL GROUP NV | 150,000 | 3,939,000 | 1.28% | ||
| 35 | VITAE PHARMACEUTICALS INC | 289,200 | 4,164,000 | 1.35% | ||
| 36 | SAGE THERAPEUTICS | 57,500 | 4,198,000 | 1.36% | ||
| 37 | IRONWOOD PHARMACEUTICALS INC COM CL A | 350,000 | 4,221,000 | 1.37% | ||
| 38 | CYNAPSUS THERAPEUTICS INC | 262,696 | 4,279,000 | 1.39% | ||
| 39 | ZELTIQ AESTHETICS INCORPORATED | 150,000 | 4,421,000 | 1.43% | ||
| 40 | VANDA PHARMACEUTICALS INC COM | 350,000 | 4,442,000 | 1.44% | ||
| 41 | CELLECTIS S A | 125,000 | 4,510,000 | 1.46% | ||
| 42 | PTC THERAPEUTICS INC | 100,000 | 4,813,000 | 1.56% | ||
| 43 | ENDOCHOICE HLDGS INC | 300,000 | 4,905,000 | 1.59% | ||
| 44 | UNIQURE NV | 185,000 | 4,995,000 | 1.62% | ||
| 45 | Anacor Pharmaceuticals Inc | 65,000 | 5,033,000 | 1.63% | ||
| 46 | AETNA INC NEW | 40,000 | 5,098,000 | 1.65% | ||
| 47 | DEXCOM | 65,000 | 5,199,000 | 1.68% | ||
| 48 | Atara Biotherapeutics Inc | 100,000 | 5,276,000 | 1.71% | ||
| 49 | AMICUS THERAPEUTICS INC | 375,000 | 5,306,000 | 1.72% | ||
| 50 | NEUROCRINE BIOSCIE COM USD0.001 | 122,500 | 5,851,000 | 1.90% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-034669, filed 2015.09.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
